ExeVir

0 followers

Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development as a COVID-19 therapeutic.

Industries

Headquarters

Employees

Links

Org chart

Torsten Mummenbrauer

CEO

Torsten Mummenbrauer

Collapse

Fiona Du Monceau

COO

Xavier Saelens

Scientific Founder & Research Collaborator

Nico Callewaert

Scientific Founder & Research Collaborator

Antoine THOMAS

Head of External Manufacturing

Fiona du Monceau - de Hemptinne

Chief Operations Officer

Philippe Monteyne

Co-Founder and Board Member (Chairman till March 2022)

Viki Bockstal

Head of Preclinical Development

Teams

View all

Board of Directors

9 members

Leadership Team

4 members

CEO and Executive Team

2 members

Founding Team

2 members

Discover similar companies

Venly

49 followers

Tata Motors

136 followers

Tata Communications

59 followers

Bombardier

36 followers

ثمَانِيَة

47 followers